UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000004514
Receipt No. R000005397
Scientific Title A phase II study of PAD therapy (bortezomib, doxorubicin, and dexamethasone) for relapsed or refractory multiple myeloma.
Date of disclosure of the study information 2010/11/09
Last modified on 2014/02/24 10:00:31

No. Disposal Last modified on Item of update
1 Insert 2010/11/08 12:55:08
2 Update 2012/09/10 10:37:26 Recruitment status
3 Update 2014/02/24 10:00:31 Email
Last name of contact person
Last name of contact person
Address
Post marketing survey by drug manufacture etc., specified by Japanese law.


Contact us.